U.S. authorities recognize emergency use of "lemdecivir" effective on new corona 8:51 on May 2
U.S. President Trump has revealed that the drug "lemdecivir", which is being studied for its effect on the new coronavirus, has been approved for emergency use by the drug review authorities.
Remdecivir is a drug that Gilead Sciences, headquartered in the United States, has been developing as a therapeutic drug for Ebola hemorrhagic fever, and it has been pointed out that it may be effective in the treatment of new coronaviruses.
President Trump revealed to the reporters at the White House on the 1st that the FDA (Food and Drug Administration), which examines drugs in the United States, has approved the emergency use of lemdesibir.
Although the US government approved "extended use" in January, which allows the use of lemdecivir in some cases, approval of emergency use will allow wider use for severely ill patients. I will.
President Trump expressed his expectations, saying, "It's a very promising situation. It will give great results."
With regard to lemdecivir, clinical trials are being conducted to confirm the efficacy and safety in each country. Last month, a part of a clinical trial conducted by the US National Institutes of Health (NIH) to examine the therapeutic efficacy of new coronavirus in patients. It has been confirmed that the results of the analysis confirmed that it will accelerate the recovery of patients.
The FDA says that there is still limited information on its efficacy and safety, unlike formal approval that has been approved for emergency procedures.